How do I apply for NRC — Preclinical in vivo facility?

Visit Government of Canada, National Research Council Canada's website for application instructions.

What industries are eligible for NRC — Preclinical in vivo facility?

Eligible industries include: biotechnology, biopharmaceutical.

Who administers NRC — Preclinical in vivo facility?

This program is administered by Government of Canada, National Research Council Canada.

Are there similar programs to NRC — Preclinical in vivo facility?

Yes! Canada Grants Database has similar programs in the Research & Innovation Partnerships category. Browse our database to find more options that match your needs.

NRC — Preclinical in vivo facility

Q: What benefits does NRC — Preclinical in vivo facility provide?

NRC — Preclinical in vivo facility offers: scientific services, access to facilities, advisory. Access to NRC's cutting-edge preclinical in vivo facility, specialized equipment, and multi-disciplinary expertise for the evaluation and functional characterization of biologics and vaccines. This includes validation of therapeutic targets, efficacy studies, animal model development, and advanced molecular imaging, generating critical data for Investigational New Drug (IND) applications.

Government of Canada, National Research Council Canada

🔬 Research & Innovation Partnerships🔬 Research💼 Commercialization📍 Regional🏪 Small Business📈 Growth

Preclinical in vivo facility for biologics and vaccines in Ottawa

Funding

Contact for details

Deadline

Mar 19, 2019

Status

Rolling Intake

What Is This Program?

Fee-for-service facility that enables clients to validate their biologics and vaccine design approaches and obtain a clear picture of the preclinical safety and efficacy of their products.

What Benefits Are Offered?

scientific servicesaccess to facilitiesadvisory

Access to NRC's cutting-edge preclinical in vivo facility, specialized equipment, and multi-disciplinary expertise for the evaluation and functional characterization of biologics and vaccines. This includes validation of therapeutic targets, efficacy studies, animal model development, and advanced molecular imaging, generating critical data for Investigational New Drug (IND) applications.

Who Is Eligible?

Industries: biotechnology, biopharmaceutical

Other Criteria: companies developing biologics or vaccines, requiring preclinical in vivo evaluation and functional characterization, seeking to generate critical data for Investigational New Drug (IND) applications